Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

SOLACI in Support of the Stent — Save a Life! Initiative

The Latin American Society of Interventional Cardiology has signed a cooperation agreement with the Stent — Save a Life! Initiative, a project created by the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and PCR in 2009. Its aim is to reduce morbidity and mortality in patients with acute coronary syndromes worldwide. The mission of this Initiative is to save lives by improving access to guidelines complying with primary percutaneous coronary intervention therapies in patients suffering from acute myocardial infarction all over the world.

SOLACI SSL

The agreement was signed on May 20th, 2019, during the annual Stent – Save a Life! Initiative forum held a day before the EuroPCR 2019 Congress in Paris. During the same event, Uruguay also signed a cooperation and endorsement agreement with the Initiative through attendees Dr. Ignacio Batista and Dr. Jorge Mayol.

Additionally, SOLACI commends Dr. Jorge Belardi (former SOLACI president) and Dr. Jorge Mayol (former SOLACI Sessions director) for their participation as this year’s coordinators of the scientific program for this event and as Latin American representatives for the Stent — Save a Life! Initiative. Moreover, Dr. Alfonsina Candiello, SOLACI member and Stent — Save a Life! Country Champion for Argentina, took part in the team responsible for the elaboration of a new project called Blueprint Project.

SOLACI celebrates and endorses all activities conducted by the Initiative, and vows to continue searching for the best possible treatment for patients with acute myocardial infarction worldwide.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

SOLACI Presented an Outstanding Scientific Session on Complex Coronary Lesions at EuroPCR 2026

The Latin American Society of Interventional Cardiology (SOLACI) had a prominent participation at EuroPCR 2026 through an institutional scientific session held on May 21...

Relive SOLACI’s participation in the V International Congress of Clinical and Interventional Cardiology in the Dominican Republic

The Latin American Society of Interventional Cardiology actively participated in the “V International Congress of Clinical and Interventional Cardiology”, organized by the Asociación Dominicana...

SOLACI to Participate in EuroPCR 2026 with a Scientific Session Focused on the Management of Complex Coronary Lesions

The Latin American Society of Interventional Cardiology will have a prominent participation at EuroPCR 2026 through an institutional scientific session bringing together renowned international...

The Preliminary Scientific Program for SOLACI & SBHCI 2026 Is Now Available

The SOLACI & SBHCI 2026 Congress is already beginning to take shape with the official release of its Preliminary Scientific Program — a high-impact...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...